This
table summarises information about HIV drugs including
the latest prices at which antiretrovirals are being
offered to developing countries, and the terms of
the offers. Some of these offers are being made
through the UNAIDS Accelerating Access Initiative;
others are being offered through programmes established
by the companies themselves. This table will be
regularly updated as more information becomes available.
View treatment and cost options: Option
1, Option
2, Option
3 -2002 |
Option 1, Option
2, Option
3. - 2001
|
|
Drug
|
Special Provisions*
|
Discount* Price
|
Formulary
|
Standard Dosage
|
Generic Alternative |
Protease
Inhibitors (PI)
|
Agenerase
amprenavir
|
|
discounted
by 50% from the wholesale price $16.80 per day
($6,132.00 annually) to
$8.70
per day,
$3175 per year
|
Available as 50 and 150 mg soft-gelatin capsules.
|
eight 150 mg capsules (1,200
mg) every 12 hours twice daily
16 capsules a day
|
|
Crixivan
indinavir
|
Africa
Romania
Haiti
Brazil
Available to NGOs and company health plans, as
well as govts
|
$600
per year
|
200mg
400mg
|
The standard dose is two 400 mg capsules every
8 hours. It should be taken with water, and without
food or with a very low-fat light meal and at
least 1 hour before or 2 hours after a regular
meal.
6 capsules a day
|
|
Fortovase
saquinavir
also called:
soft-gel cap
|
Available to least developed
nations at negotiable prices
- Roche is seeking to offer the drug at cost and
offer research grants to those providing clinical
care
|
c.
$1300 if dosed once daily with ritonavir, or $2400
if dosed at 1200mg three times daily
|
200 mg
|
1,200 mg (six 200 mg capsules) every 8 hours.
18 capsules a day
|
none |
Invirase
saquinavir
also called:
hard-gel cap
Top
|
Available
to least developed nations at negotiable prices
- Roche is seeking to offer the drug at cost and
offer research grants to those providing clinical
care
|
c.
$1300 if dosed once daily with ritonavir, or $2400
if dosed at 1200mg three times daily
|
|
600 mg (three 200 mg capsules) every 8 hours
12 capsules a day.
|
|
Kaletra
lopinavir
/ ritonavir
|
Africa
(available to private sector or company health
plans and NGOs, as well as govts)
|
c.$1,000
per year
|
Available in capsule form.
Each contains 133 mg of lopinavir and 33 mg of
ritonavir.
Also available in oral solution 100mg/ml
|
3 capsules twice a day (approx 500mg of drug)
6 capsules daily
5 ml oral solution twice daily
|
None |
Norvir
ritonavir
Top
|
Africa
(available to private sector or company health
plans and NGOs, as well as govts)
|
c.
$1,000 per
year
|
100 mg tab
80mg/ml oral solution
|
six 100 mg capsules (600 mg) every 12 hours.
12 capsules daily
or
7.5 ml (1 ˝ teaspoons twice daily )
|
India |
Viracept
nelfinavir
Top
|
|
Average
cost $5650 pa
Price
will be reduced by 15% , but only as a rebate
bringing it down to
$4807
per year
|
250mg tablet
50mg oral powder
|
Three 250 mg tablets (750 mg) every 8 hours
with food (a meal or light snack).
6 tablets a day
Powder has 50mg per 1g of powder. Used in children or those
who have difficulty swallowing
|
|
|
|
Non-Nucleoside
Reverse Transcriptase Inhibitors (NNRTIs)
|
Rescriptor
delavirdine
|
|
not offered
as discounted
Wholesale
price $7.60 per day ($2,696 annually
|
100mg tab
|
Four 100 mg tablets
every 8 hours, 3 times daily
12 capsules a day
|
|
Sustiva
efavirenz
|
Africa
Romania
Haiti
Brazil
Available to NGOs and company health plans, as
well as govts
|
$500
per year |
200 mg capsules
|
Three 200 mg capsules once a day
|
|
Viramune
nevirapine
Top
|
Maternal/infant
treatment free to all non-EU countries
(also excludes USA, Canada, NZ, Australia, Japan,
Switzerland, Norway, Iceland)
|
Free
as two doses for mother and infant treatment
$1.22 per day for adult dosing ($445 p.a)
|
200mg
|
One 200 mg tablet twice daily (every 12 hours)
|
India:
Cipla (Nevimune$340 p.a)
Hetero
($202)
|
|
|
Nucleoside
Reverse Transcriptase Inhibitors (NRTIs)
|
Combivir
zidovudine
/ lamivudine
|
Developing
countries - govts, NGOs and workplace initiatives
where suitable medical infrastructure exists,
via UNAIDSAccelerating Access Initiative
|
$2
per day
$730
per year
|

Contains 300 mg of Retrovir plus 150 mg of Epivir
|
One pill twice a day (every twelve hours)
2 capsules a day
|
Brazil
India
Cipla - $635
Hetero - $293 |
Epivir
lamivudine
Also
called: 3TC
Top
|
Developing
countries - govts, NGOs and workplace initiatives
where suitable medical infrastructure exists, via
UNAIDSAccelerating Access Initiative
|
58
cents per day
$212
per year
|
150 mg tab
10mg per ml (50mg in a teaspoon approx 5ml).
|
150 mg every twelve hours for
adults over 50kg
2mg /kg every twelve hours for adults 50kg or
less
(see Combivir)
|
Brazil
India
Cipla $190
Hetero $98 |
Hivid
zalcitabine
also called: ddC
|
|
Available
at cost
retail prices vary from $150 - $200 per 100 tabs
approx which costs
from $3285 - $4380
|
0.375mg
0.75mg
|
0.75 mg every 8 hours three times a day
(2.25 mg of Hivid per day divided into three doses)
|
Brazil
|
Retrovir
zidovudine
also called: AZT
Top
|
Developing
countries - govts, NGOs and workplace initiatives
where suitable medical infrastructure exists, via
UNAIDSAccelerating Access Initiative
|
95% reduction on "average
global price"
was
$2000 pa in 1997 which equates to
$100 per year discounted
|
100mg
300mg
50mg per ml syrup
|
300 mg every 12 hours
(also
see combivir)
|
Brazil
India |
Videx
didanosine
also called:ddI
Top
|
Not available
to private sector/company health plans
|
80 cents per
day
$0.80 per day
$292
per year
|
25mg tabs
50 mg
100 mg
150 mg
|
2 tablets every
twelve hours (twice a day)
|
Not
patented in Africa
Thailand
Brazil
India |
Zerit
stavudine
aslo called: d4T
|
Not
available to private sector/company health plans
|
15
cents a day/$54 per year |
15 mg capsules

20 mg
40 mg
|
Adult over 60kg - 40mg every twelve
hours
Adult under 60kg – 30 mg every twelve hours
|
Thailand
Brazil
India
Cipla $70
Hetero $47
|
Ziagen
abacavir
Top
|
Developing
countries - govts, NGOs and workplace initiatives
where suitable medical infrastructure exists,
via UNAIDSAccelerating Access Initiative
|
It
was hoped that there would be a 95% reduction
on "average global price" which
was $3000 pa in 1998 and
equates to $150 per year
However
Glaxo have announced a reduction from $10.68 per
day ($3898 per yr) to $3.80 per day ($1387 per
yr)
|
300 mg tablet and an oral solution
20 mg/ml
|
one 300 mg tablet every
12 hours or twice daily
|
none |
|
|
|
|
|
|
|